STADA Revenue and Competitors

Bad Vilbel,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • STADA's estimated annual revenue is currently $1.5B per year.(i)
  • STADA's estimated revenue per employee is $201,000

Employee Data

  • STADA has 7221 Employees.(i)
  • STADA grew their employee count by 7% last year.

STADA's People

NameTitleEmail/Phone
1
CIO / SVP ITReveal Email/Phone
2
CFO Emerging MarketsReveal Email/Phone
3
Chief Compliance OfficerReveal Email/Phone
4
Personal Assistant to VP BiotechnologyReveal Email/Phone
5
CEOReveal Email/Phone
6
Personal Assistant to VP Regulatory, Medical & Clinical AffairsReveal Email/Phone
7
CFO Germany/ Vorstand Finanzen bei der Stada Arzneimittel AGReveal Email/Phone
8
PA to VP Corporate Treasury, PA to VP Corporate Accounting & TaxReveal Email/Phone
9
VPReveal Email/Phone
10
SVP Global OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is STADA?

As STADA, we follow our purpose of "Caring for people's health as a trusted partner". In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare products such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories. In financial year 2019, STADA achieved adjusted Group sales of EUR 2,608.6 million. Headquartered in Bad Vilbel, Germany, the main drivers of the success are the committed and highly-motivated 11,100 employees (as of December 31, 2019). Are you looking for an exciting job opportunity to advance your career in the healthcare industry? Explore our job vacancies: www.stada.com/career Data Privacy Policy & Imprint: www.stada.com/data-protection, www.stada.com/imprint

keywords:N/A

N/A

Total Funding

7221

Number of Employees

$1.5B

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

STADA News

2022-04-17 - Stada Recruits Ex-Sandoz Exec To Help Steer Biosimilars

Stada has announced the appointment of former Sandoz executive Christine Berndt as head of global development for specialty and biosimilar...

2022-04-13 - STADA brings in Christine Berndt to head specialties and ...

German drugmaker STADA Arzneimittel (SAZ: Xetra) will from June add to its team by welcoming Dr Christine Berndt as head of global...

2022-03-30 - Alvotech and STADA Pave Way to Launching HUKYNDRA ...

STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. The company focuses on a three-pillar strategy consisting of generics, specialty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1451.4M72217%N/A